Actinium Pharmaceuticals Statistics
Total Valuation
ATNM has a market cap or net worth of $39.91 million. The enterprise value is -$396,026.
Important Dates
The last earnings date was Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATNM has 31.18 million shares outstanding. The number of shares has increased by 1.00% in one year.
| Current Share Class | 31.18M |
| Shares Outstanding | 31.18M |
| Shares Change (YoY) | +1.00% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 20.26% |
| Float | 30.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 446.86 |
| Forward PS | n/a |
| PB Ratio | 17.57 |
| P/TBV Ratio | 17.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.89, with a Debt / Equity ratio of 0.66.
| Current Ratio | 5.89 |
| Quick Ratio | 5.73 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -167.66% and return on invested capital (ROIC) is -103.04%.
| Return on Equity (ROE) | -167.66% |
| Return on Assets (ROA) | -27.95% |
| Return on Invested Capital (ROIC) | -103.04% |
| Return on Capital Employed (ROCE) | -66.98% |
| Weighted Average Cost of Capital (WACC) | 3.53% |
| Revenue Per Employee | $3,600 |
| Profits Per Employee | -$938,840 |
| Employee Count | 25 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.37% in the last 52 weeks. The beta is -0.11, so ATNM's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -16.37% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 53.24 |
| Average Volume (20 Days) | 248,860 |
Short Selling Information
The latest short interest is 1.09 million, so 3.51% of the outstanding shares have been sold short.
| Short Interest | 1.09M |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 3.51% |
| Short % of Float | 3.55% |
| Short Ratio (days to cover) | 6.49 |
Income Statement
In the last 12 months, ATNM had revenue of $90,000 and -$23.47 million in losses. Loss per share was -$0.76.
| Revenue | 90,000 |
| Gross Profit | 90,000 |
| Operating Income | -25.51M |
| Pretax Income | -23.47M |
| Net Income | -23.47M |
| EBITDA | -25.35M |
| EBIT | -25.51M |
| Loss Per Share | -$0.76 |
Full Income StatementBalance Sheet
The company has $42.13 million in cash and $1.52 million in debt, with a net cash position of $40.61 million or $1.30 per share.
| Cash & Cash Equivalents | 42.13M |
| Total Debt | 1.52M |
| Net Cash | 40.61M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 2.30M |
| Book Value Per Share | 0.07 |
| Working Capital | 35.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.88 million and capital expenditures -$106,000, giving a free cash flow of -$22.98 million.
| Operating Cash Flow | -22.88M |
| Capital Expenditures | -106,000 |
| Depreciation & Amortization | 165,000 |
| Net Borrowing | -11,000 |
| Free Cash Flow | -22.98M |
| FCF Per Share | -$0.74 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -28,346.67% |
| Pretax Margin | -26,078.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.00% |
| Shareholder Yield | -1.00% |
| Earnings Yield | -58.36% |
| FCF Yield | -57.15% |
Analyst Forecast
The average price target for ATNM is $4.50, which is 251.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 251.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 196.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.
| Last Split Date | Aug 11, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
